- Home
- ARBB vs BCLI Comparison
ARBB vs BCLI Comparison
Compare ARBB & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- BCLI
- Stock Information
- Founded
- ARBB 1997
- BCLI 2000
- Country
- ARBB Singapore
- BCLI United States
- Employees
- ARBB N/A
- BCLI N/A
- Industry
- ARBB EDP Services
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARBB Technology
- BCLI Health Care
- Exchange
- ARBB Nasdaq
- BCLI Nasdaq
- Market Cap
- ARBB 11.9M
- BCLI 9.8M
- IPO Year
- ARBB 2023
- BCLI N/A
- Fundamental
- Price
- ARBB $6.96
- BCLI $1.22
- Analyst Decision
- ARBB Strong Buy
- BCLI Strong Buy
- Analyst Count
- ARBB 1
- BCLI 1
- Target Price
- ARBB $20.00
- BCLI $30.00
- AVG Volume (30 Days)
- ARBB 17.5K
- BCLI 526.0K
- Earning Date
- ARBB 06-27-2025
- BCLI 08-13-2025
- Dividend Yield
- ARBB N/A
- BCLI N/A
- EPS Growth
- ARBB N/A
- BCLI N/A
- EPS
- ARBB N/A
- BCLI N/A
- Revenue
- ARBB $24,425,491.00
- BCLI N/A
- Revenue This Year
- ARBB N/A
- BCLI N/A
- Revenue Next Year
- ARBB N/A
- BCLI N/A
- P/E Ratio
- ARBB N/A
- BCLI N/A
- Revenue Growth
- ARBB N/A
- BCLI N/A
- 52 Week Low
- ARBB $3.22
- BCLI $0.72
- 52 Week High
- ARBB $18.60
- BCLI $6.60
- Technical
- Relative Strength Index (RSI)
- ARBB 43.03
- BCLI 53.63
- Support Level
- ARBB $6.48
- BCLI $1.08
- Resistance Level
- ARBB $7.46
- BCLI $1.28
- Average True Range (ATR)
- ARBB 0.63
- BCLI 0.10
- MACD
- ARBB 0.14
- BCLI 0.01
- Stochastic Oscillator
- ARBB 75.92
- BCLI 57.69
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.